Clinical Trial Update: Alvopem® (Pemetrexed) Safety Assessment

View source ↗

Summary

Safety data from completed trials of Alvopem (pemetrexed) have been assessed and results are now posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma
• Non-small Cell Lung Cancer

Drugs mentioned

• Alvopem (pemetrexed)

Snippet

Sponsor: NanoAlvand | Conditions: Non Small Cell Lung Cancer, Malignant Pleural Mesothelioma | Status: COMPLETED | Results posted: 2024-10-23